HUP1400519A2 - Crystalline form of laquinimod and sodium salt thereof useful for the preparation of pharmaceutical compositions - Google Patents
Crystalline form of laquinimod and sodium salt thereof useful for the preparation of pharmaceutical compositionsInfo
- Publication number
- HUP1400519A2 HUP1400519A2 HU1400519A HUP1400519A HUP1400519A2 HU P1400519 A2 HUP1400519 A2 HU P1400519A2 HU 1400519 A HU1400519 A HU 1400519A HU P1400519 A HUP1400519 A HU P1400519A HU P1400519 A2 HUP1400519 A2 HU P1400519A2
- Authority
- HU
- Hungary
- Prior art keywords
- laquinimod
- useful
- preparation
- pharmaceutical compositions
- sodium salt
- Prior art date
Links
- GKWPCEFFIHSJOE-UHFFFAOYSA-N laquinimod Chemical compound OC=1C2=C(Cl)C=CC=C2N(C)C(=O)C=1C(=O)N(CC)C1=CC=CC=C1 GKWPCEFFIHSJOE-UHFFFAOYSA-N 0.000 title 1
- 229960004577 laquinimod Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 159000000000 sodium salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU1400519A HUP1400519A2 (en) | 2014-11-03 | 2014-11-03 | Crystalline form of laquinimod and sodium salt thereof useful for the preparation of pharmaceutical compositions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU1400519A HUP1400519A2 (en) | 2014-11-03 | 2014-11-03 | Crystalline form of laquinimod and sodium salt thereof useful for the preparation of pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP1400519A2 true HUP1400519A2 (en) | 2016-05-30 |
Family
ID=89991634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU1400519A HUP1400519A2 (en) | 2014-11-03 | 2014-11-03 | Crystalline form of laquinimod and sodium salt thereof useful for the preparation of pharmaceutical compositions |
Country Status (1)
| Country | Link |
|---|---|
| HU (1) | HUP1400519A2 (en) |
-
2014
- 2014-11-03 HU HU1400519A patent/HUP1400519A2/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL282584A (en) | Quinoline derivatives and pharmaceutical compositions containing them | |
| IL258082B (en) | Bezimidazole derivatives and pharmaceutical compositions containing them | |
| IL247062A0 (en) | Heterocyclic compounds , their preparation and compositions pharmaceutical containing them | |
| IL250882A0 (en) | Novel pharmaceutical composition containing hydroxamic acid derivative or salt thereof | |
| IL258922A (en) | Methods for the preparation of obeticholic acid and derivatives thereof | |
| PT3580219T (en) | Process for the preparation of remimazolam and solid state forms of remimazolam salts | |
| IL249803A0 (en) | Azepanyl derivatives and pharmaceutical compositions containing them | |
| IL241038A0 (en) | Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same | |
| IL248090A0 (en) | Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions | |
| IL249308A0 (en) | Quinoline derivatives their preparation, and pharmaceutical compositions containing them | |
| IL260040A (en) | Complexes of celecoxib and its salts and derivatives process for the preparation thereof and pharmaceutical compositions containing them | |
| SG10202008700VA (en) | α-TRUXILLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF | |
| ZA201700843B (en) | Oral pharmaceutical composition of isotretinoin | |
| EP3302099A4 (en) | Enhanced salt compositions and methods of preparation thereof | |
| IL245415A0 (en) | Process for the preparation of methylphenidate and pharmaceutical salts thereof | |
| PT3398946T (en) | Salt of morpholine derivative and crystalline form thereof, as well as preparation method, pharmaceutical composition and use of the same | |
| HUP1400519A2 (en) | Crystalline form of laquinimod and sodium salt thereof useful for the preparation of pharmaceutical compositions | |
| HUP1600415A2 (en) | Pimavanserin salts for the manufacture of pharmaceutical formulations | |
| HUP1400520A2 (en) | Laquinimod salts useful for the preparation of pharmaceutical compositions | |
| ZA201804036B (en) | Pulsatile release pharmaceutical composition comprising naftazone or one of its salts | |
| GB2569616B (en) | Sustained release oral pharmaceutical compositions of dicycloverine | |
| HUP1600436A2 (en) | Salts for the preparation of a pharmaceutical composition | |
| ZA201400446B (en) | Pharmaceutical composition comprising aripiprazole or salt thereof | |
| HUP1400123A2 (en) | Salts of sunitinib, their polymorphs and pharmaceutical compositions comprising them | |
| EP3222271A4 (en) | Stable pharmaceutical composition comprising pemetrexed or pharmaceutically acceptable salt thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC4A | Lapse of provisional application due to refusal |